Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Leukemia, B-Cell × Lansoprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Pseudomyxoma Peritonei 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, B-Cell 1 Endometrial Neoplasms 1 Appendiceal Neoplasms 1

Interventions

Cyclophosphamide 9 ofatumumab 8 fludarabine 5 Rituximab 5 fludarabine phosphate 4 Bendamustine Hydrochloride 4 venetoclax 3 ibrutinib 3 acalabrutinib 3 Melphalan 3 obinutuzumab 2 Whole-Body Irradiation 2 Vincristine 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Lenalidomide 2 Immunotherapy, Adoptive 2 Busulfan 2 Bortezomib 2 Alemtuzumab 2 zanubrutinib 1 thymoglobulin 1 tenofovir alafenamide 1 pomalidomide 1 pivalyloxymethyl butyrate 1 pirtobrutinib 1 pegaspargase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01279252 2019-01-25

CLEAR

King's College Hospital NHS Trust

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡